1.WHO. Eliminating measles and rubella and prevention congenital rubella infection. WHO European region strategic plan 2005–2010. World Health Organization, 2005 (http:/www.euro.who.int/document/E87772.pdf). Accessed July 2009.
2.El Belazi, G, Holzmann, H, Strauß, R. Measles in Austria, 2003–2005 [in German]. Mitteilungen der Sanitätsverwaltung 2007; 108: 5–7.
6.Hanratty, B, et al. UK measles outbreak in non-immune anthroposophic communities: the implications for the elimination of measles from Europe. Epidemiology and Infection 2000; 125: 377–383.
7.Orenstein, WA. Field evaluation of vaccine efficacy. Bulletin of the World Health Organization 1985; 63: 1055–1068.
8.European Parliament. Commission Decision of 28/IV/2008 amending Decision 2002/253/EC laying down case definitions for reporting communicable diseases to the Community network under Decision No. 2119/98/EC of the European Parliament and of the Council.
9.El Mubarak, HS, et al. Development of a semi-quantitative real-time RT-PCR for the detection of measles virus. Journal of Clinical Virology 2005; 32: 313–317.
10.Santibanez, S, et al. Rapid replacemant of endemic measles virus genotypes. Journal of General Virology 2002; 83: 2699–2708.
13.Wichmann, O, et al. Large measles outbreak at a German public school, 2006. Pediatric Infectious Disease Journal 2007; 26: 782–786.
14.Yeung, LF, et al. A limited measles outbreak in a highly vaccinated US boarding school. Pediatrics 2005; 116: 1287–1291.
15.Vitek, CR, et al. Increased protections during a measles outbreak of children previously vaccinated with a second dose of measles-mumps-rubella vaccine. Pediatric Infectious Disease Journal 1999; 18: 620–623.
16.Marin, M, et al. Measles transmission and vaccine effectiveness during a large outbreak on a densely populated island: implications for vaccination policy. Clinical Infectious Diseases 2006; 42: 315–319.
17.Muscat, M, et al. Measles in Europe: an epidemiological assessment. Lancet 2009; 373: 383–389.
18.Alm, JS, et al. Atopy in children of families with an anthroposophical lifestyle. Lancet 1999; 353: 1485–1488.
19.Hanratty, B, et al. UK measles outbreak in non-immune anthroposophic communities: the implications for the elimination of measles from Europe. Epidemiology and Infection 2000; 125: 377–383.
21.DuVell, E. Attitudes of parents towards measles and immunisation after a measles outbreak in an anthroposophical community. Journal of Epidemiology and Community Health 2001; 55: 685–686.
22.van den Hof, S, et al. Measles outbreak in a community with very low vaccine coverage in the Netherlands. Emerging Infectious Disease 2001; 7: 593–597.
23.Parker, AA, et al. Implications of a 2005 measles outbreak in Indiana for sustained elimination of measles in the United States. New England Journal of Medicine 2006; 355: 447–455.
25.Stein-Zamir, C, et al. Measles outbreaks affecting children in Jewish ultra-orthodox communities in Jerusalem. Epidemiology and Infection 2008; 136: 207–214.
26.World Health Organization. WHO guidelines for epidemic preparedness and response to measles outbreaks. Geneva, Switzerland, May 1999, p. 56 (WHO/CDS/CSR/ISR/99.1).
27.Walling, J, Heinjne Kretzschmar, M. A measles epidemic threshold in a highly vaccinated population. PLoS Medicine 2005; 2: e316. Published online: 18 October 2005. doi: 10.1371/journal.pmed.0020316.
28.Ringler, M, et al. Fully vaccinated children are rare: immunization coverage and seroprevalence in Austrian school children. European Journal of Epidemiology 2003; 18: 161–170.
29.Wichmann, O, et al. Measles elimination in Germany. Further efforts needed to achieve measles elimination in Germany: results of an outbreak investigation. Bulletin of the World Health Organization 2009; 87: 108–115.
31.Szilagyi, PG, et al. Reducing geographic, racial, and ethnic disparities in childhood immunization rates by using reminder/recall interventions in urban primary care practices. Pediatrics 2002; 110: e58 (http://www.pediatrics.org/cgi/content/full/110/5/e58). Accessed July 2009.